Trials / Unknown
UnknownNCT03259256
Islet Allotransplantation for Type 1 Diabetic Patients
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if islet cell transplantation , is an effective treatment for type 1 diabetes. Study participants may receive up to three islet transplants and will be followed for five years to monitor blood sugar control, islet transplant function, and changes in quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Allogeneic transplantation of intrahepatic islet | Allogeneic transplantation of intrahepatic islet is one of the effective methods for diabetic therapy |
Timeline
- Start date
- 2017-04-23
- Primary completion
- 2018-08-31
- Completion
- 2019-06-30
- First posted
- 2017-08-23
- Last updated
- 2017-09-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03259256. Inclusion in this directory is not an endorsement.